March 2018 Issue of MMM
Now more than ever, patients aren't shy about sharing their wants and needs. Here, 8,000 patients from three generations in the U.S., U.K., Germany, and ...
Purdue's decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?
As HCPs continue to be stretched for time to diagnose and interact with patients, health bots could help reduce HCP workload and drive patient engagement.
Spark has priced its cure for a rare form of blindness at $425,000 per eye. But rather than the science or the cost, pharma is ...
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
As oncology drugs save or extend the lives of many more patients than anyone could have imagined a few years ago, a new challenge has ...
The general sense: Nobody should get comfortable with the status quo
Pharma has backed a number of AR-based games for physician learning and marketing. They're meant to complement live learning, but mobile games may do a ...
When Ortho Clinical Diagnostics lived under the roof of Johnson & Johnson, it had the luxury of focusing on its product and service mix — ...
She is overseeing three of the network's agencies in the newly created role.
The network also appointed her predecessor, Nick Colucci, as COO of Publicis Communications North America, effective immediately.
Burcin, who joins from Klick Health, is the former Global CEO of Havas Health.
Daniel Carucci is joining the Interpublic Group firm full-time after serving as a consultant and in roles with the U.N. Foundation and the U.S. Navy.
For some pharma brands, the price tag is just too high. For others, the platform isn't serious enough.
Today's effective communicators must be comfortable with change, learn how to anticipate it, and adapt messaging to key audiences.
Recently, Forbes ran an article from Wild Pixel Media founder and CEO Carlos Machicao lamenting the fact that healthcare advertising is boring.
More than ever, marketers and agencies have a powerful role in shaping public health, curbing harmful behaviors, and promoting good ones among at-risk communities and ...
At Work With
The CEO of the independent healthcare agency discusses growing a business in digital in the early 2000s and the perks of remaining independent.
Acquisitions that were applauded a few years ago, such as Teva's purchase of Allergan's generic business, now look like lemons.